Preliminary Techno-Economic Assessment of Animal Cell-Based Meat
Interest in animal cell-based meat (ACBM) or laboratory-grown meat has been increasing; however, the economic viability of these potential products has not been thoroughly vetted. Recent studies suggest monoclonal antibody production technology can be adapted for the industrialization of ACBM produc...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Foods |
Subjects: | |
Online Access: | https://www.mdpi.com/2304-8158/10/1/3 |
id |
doaj-57f3ef9d9c47461794e45050bb069df1 |
---|---|
record_format |
Article |
spelling |
doaj-57f3ef9d9c47461794e45050bb069df12020-12-23T00:00:38ZengMDPI AGFoods2304-81582021-12-01103310.3390/foods10010003Preliminary Techno-Economic Assessment of Animal Cell-Based MeatDerrick Risner0Fangzhou Li1Jason S. Fell2Sara A. Pace3Justin B. Siegel4Ilias Tagkopoulos5Edward S. Spang6Department of Food Science and Technology, University of California, Davis, CA 95616, USADepartment of Computer Science, University of California, Davis, CA 95616, USAGenome Center, University of California, Davis, CA 95616, USADepartment of Food Science and Technology, University of California, Davis, CA 95616, USAGenome Center, University of California, Davis, CA 95616, USADepartment of Computer Science, University of California, Davis, CA 95616, USADepartment of Food Science and Technology, University of California, Davis, CA 95616, USAInterest in animal cell-based meat (ACBM) or laboratory-grown meat has been increasing; however, the economic viability of these potential products has not been thoroughly vetted. Recent studies suggest monoclonal antibody production technology can be adapted for the industrialization of ACBM production. This study provides a scenario-based assessment of the projected cost per kilogram of ACBM produced in the United States based on cellular metabolic requirements and process/chemical engineering conventions. A sensitivity analysis of the model identified the nine most influential cost factors for ACBM production out of 67 initial parameters. The results indicate that technological performance will need to approach technical limits for ACBM to achieve profitably as a commodity. However, the model also suggests that low-volume high-value specialty products could be viable based on current technology.https://www.mdpi.com/2304-8158/10/1/3cultured meatcell-based meattechno-economic assessmentbioreactorprocess engineeringbioengineering |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Derrick Risner Fangzhou Li Jason S. Fell Sara A. Pace Justin B. Siegel Ilias Tagkopoulos Edward S. Spang |
spellingShingle |
Derrick Risner Fangzhou Li Jason S. Fell Sara A. Pace Justin B. Siegel Ilias Tagkopoulos Edward S. Spang Preliminary Techno-Economic Assessment of Animal Cell-Based Meat Foods cultured meat cell-based meat techno-economic assessment bioreactor process engineering bioengineering |
author_facet |
Derrick Risner Fangzhou Li Jason S. Fell Sara A. Pace Justin B. Siegel Ilias Tagkopoulos Edward S. Spang |
author_sort |
Derrick Risner |
title |
Preliminary Techno-Economic Assessment of Animal Cell-Based Meat |
title_short |
Preliminary Techno-Economic Assessment of Animal Cell-Based Meat |
title_full |
Preliminary Techno-Economic Assessment of Animal Cell-Based Meat |
title_fullStr |
Preliminary Techno-Economic Assessment of Animal Cell-Based Meat |
title_full_unstemmed |
Preliminary Techno-Economic Assessment of Animal Cell-Based Meat |
title_sort |
preliminary techno-economic assessment of animal cell-based meat |
publisher |
MDPI AG |
series |
Foods |
issn |
2304-8158 |
publishDate |
2021-12-01 |
description |
Interest in animal cell-based meat (ACBM) or laboratory-grown meat has been increasing; however, the economic viability of these potential products has not been thoroughly vetted. Recent studies suggest monoclonal antibody production technology can be adapted for the industrialization of ACBM production. This study provides a scenario-based assessment of the projected cost per kilogram of ACBM produced in the United States based on cellular metabolic requirements and process/chemical engineering conventions. A sensitivity analysis of the model identified the nine most influential cost factors for ACBM production out of 67 initial parameters. The results indicate that technological performance will need to approach technical limits for ACBM to achieve profitably as a commodity. However, the model also suggests that low-volume high-value specialty products could be viable based on current technology. |
topic |
cultured meat cell-based meat techno-economic assessment bioreactor process engineering bioengineering |
url |
https://www.mdpi.com/2304-8158/10/1/3 |
work_keys_str_mv |
AT derrickrisner preliminarytechnoeconomicassessmentofanimalcellbasedmeat AT fangzhouli preliminarytechnoeconomicassessmentofanimalcellbasedmeat AT jasonsfell preliminarytechnoeconomicassessmentofanimalcellbasedmeat AT saraapace preliminarytechnoeconomicassessmentofanimalcellbasedmeat AT justinbsiegel preliminarytechnoeconomicassessmentofanimalcellbasedmeat AT iliastagkopoulos preliminarytechnoeconomicassessmentofanimalcellbasedmeat AT edwardsspang preliminarytechnoeconomicassessmentofanimalcellbasedmeat |
_version_ |
1724373994393567232 |